AKAP9 Antikörper (AA 1075-1125)
Kurzübersicht für AKAP9 Antikörper (AA 1075-1125) (ABIN7451618)
Target
Alle AKAP9 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 1075-1125
-
Verwendungszweck
- Rabbit anti-AKAP9/CG-NAP Antibody, Affinity Purified
-
Aufreinigung
- Affinity Purified
-
Immunogen
- between AA 1075 and 1125
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
-
IP: 2 - 5 μg/mg lysate
WB: 1:2,000 - 1:10,000
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Konzentration
- 1000 μg/mL
-
Buffer
- Tris-citrate/phosphate buffer, pH 7 to 8 containing 0.09 % Sodium Azide
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- 4 °C
-
Haltbarkeit
- 12 months
-
-
- AKAP9 (A Kinase (PRKA) Anchor Protein (Yotiao) 9 (AKAP9))
-
Andere Bezeichnung
- AKAP9/CG-NAP
-
Hintergrund
- Background: AKAP9/CG-NAP is a member of the A-kinase anchoring protein family that functions as a molecular scaffold for the subcellular compartmentalization of A- kinase signaling molecules. AKAP9/CG-NAP has been found to be critical to repolarization in the human heart. Defects in AKAP9/CG-NAP result in long QT syndrome type 11, a heart disorder characterized by ventricular arrhythmia and prolonged QT intervals. AKAP9/CG-NAP has been shown to form a multiprotein complex with the I(Ks) potassium channel subunit and play an essential role in its phosphorylation by PKA. AKAP9/CG-NAP is also important to centrosome and microtubule cytoskeletal organization.
-
Gen-ID
- 10142
-
NCBI Accession
- NP_671700
-
UniProt
- Q99996
-
Pathways
- M Phase, SARS-CoV-2 Protein Interaktom
Target
-